Integrating pharmacotherapy and psychotherapy: an emerging field of study.
The mind-brain barrier is being challenged by clinicians using both medications and psychotherapy for the major psychiatric disorders. In this article, six categories of study are outlined: (1) diagnosis-specific questions, (2) psychotherapeutic aspects of randomized controlled medication trials, (3) psychotherapeutic aspects of pharmacotherapy, (4) the pharmacotherapist and the nonmedical psychotherapist triangle, (5) the meaning of medications during the stages of psychotherapy, and (6) a neurology of psychotherapy. Three categories are elaborated upon: (1) diagnosis-specific questions as they relate to disorder, (2) the meaning of medications during the stages of psychotherapy, and (3) neurology of psychotherapy.
Beitman
B D
BD
Department of Psychiatry and Neurology, University of Missouri-Columbia School of Medicine, USA.
D003131:Combined Modality Therapy; D006801:Humans; D016584:Panic Disorder / Q000188:drug therapy* / Q000628:therapy*